, Tracking Stock Market Picks
Enter Symbol:
Anacor Pharmaceuticals Inc (ANAC) [hlAlert]

up 1,570.25 %

Anacor Pharmaceuticals Inc. (ANAC) rated Outperform with price target $13 by Wedbush

Posted on: Friday,  Jan 7, 2011  8:25 AM ET by Wedbush

Wedbush rated Outperform Anacor Pharmaceuticals Inc (NASDAQ: ANAC) on 01/07/2011, when the stock price was $8.00. Since
then, Anacor Pharmaceuticals Inc has gained 1570.25% as of 01/26/2016's recent price of $133.62.
If you would have followed this Wedbush 's recommendation on ANAC, you would have gained 1570.25% of your investment in 1845 days.

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. The Company has five product candidates in clinical development. Its three product candidates include two topically administered dermatologic compounds: AN2690, an antifungal for the treatment of onychomycosis, and AN2728, an anti-inflammatory for the treatment of psoriasis, as well as a systemic antibiotic for the treatment of infections caused by Gram-negative bacteria GSK2251052 (GSK '052). The Company is developing AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis. In August 2010, it entered into a research agreement with Eli Lilly and Company (Lilly).

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/7/2011 8:25 AM Buy
8.00 13.00
as of 12/30/2011
1 Week down  -2.20 %
1 Month up  23.26 %
3 Months up  8.77 %
1 YTD down  -22.50 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy